Immunology
Congress Materials – 33rd European Paediatric Rheumatology Congress (PReS 2026)
2026 33rd European Pediatric Rheumatology Congress | Sep 16-19 | Belgrade, Serbia
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
Efficacy and Safety of Subcutaneous Ustekinumab in Paediatric Participants With Active Juvenile Psoriatic Arthritis: Results of the Open-label, Phase 3 PSUMMIT-Jr Study Through Week 52
Nicolino Ruperto, Daniel P. Hawley, Ozgur Kasapcopur, Sandrine Compeyrot-Lacassagne, Hafize Emine Sönmez, Berta Paula Magallares López, Ozge Basaran, Alejandro Brigante, Samundeeswari Deepak, Giovanni Filocamo, Sarah Ringold, Samantha Howard, Valerie Smith, Katherine Berezny, Thomas N. Kakuda, Jocelyn H. Leu, Daniel J. Lovell, Alberto Martini, and Hermine Brunner
This document will be available on Sep 16th 2026
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.
Connect with us
Connect with us
Would you like to clear and leave your conversation? Message history will be lost.